MoneyInvestor's Business Daily
The Biotech Surged 50% On Positive Data In March. Now, It's Almost Gone.
Xenon Pharmaceuticals voluntarily halted enrollment in a handful of studies Friday due to several unexpected side effects. The biotech stock crashed to a six-month low. The post The Biotech Surged 50% On Positive Data In March. Now, It's Almost Gone. appeared first on Investor's Business Daily.
Join the argument
House rules →Comments load as you scroll.